📰 Fda Authorization News
Fda Authorization News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Fda Authorization. Real-time updates on events, politics, business and more.
August 11, 2022
The US FDA approval of the Jynneos monkeypox vaccine will serve for emergency use and act as an alternative vaccine supply.
June 24, 2022
U.S. Food and Drug Administration authorized emergency use of the Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccines against COVID-19 to infants aged below 6 months.
April 28, 2022
Moderna COVID-19 vaccine for 6-month-olds receives FDA approval. Is Moderna really efficient for children below six years old?
February 2, 2022
Pfizer is now formally asking the FDA to authorize its COVID-19 vaccine for babies and toddlers.
January 4, 2022
Today FDA announced that they have approved a Pfizer booster for teenagers 12 and up for extra protection against the Omicron variant surge.
January 3, 2022
Today FDA announced that they have approved a Pfizer booster for teenagers 12 and up for extra protection against the Omicron variant surge.
January 3, 2022
Today FDA announced that they have approved a Pfizer booster for teenagers 12 and up for extra protection against the Omicron variant surge.
January 3, 2022
Today FDA announced that they have approved a Pfizer booster for teenagers 12 and up for extra protection against the Omicron variant surge.
January 3, 2022
Today FDA announced that they have approved a Pfizer booster for teenagers 12 and up for extra protection against the Omicron variant surge.
December 23, 2021
"It does work against omicron and it keeps people out of the hospital, but we do need to have enough of it to give to everyone who needs it," said Dr. Shira Doron, an epidemiologist at Tufts Medical Center.